Correlation Between PsyBio Therapeutics and Adial Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both PsyBio Therapeutics and Adial Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PsyBio Therapeutics and Adial Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PsyBio Therapeutics Corp and Adial Pharmaceuticals, you can compare the effects of market volatilities on PsyBio Therapeutics and Adial Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PsyBio Therapeutics with a short position of Adial Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of PsyBio Therapeutics and Adial Pharmaceuticals.

Diversification Opportunities for PsyBio Therapeutics and Adial Pharmaceuticals

-0.14

Correlation Coefficient

PsyBio Therapeutics  Adial Pharmaceuticals

Good diversification

The 3 months correlation between PsyBio and Adial is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding PsyBio Therapeutics Corp and Adial Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adial Pharmaceuticals and PsyBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PsyBio Therapeutics Corp are associated (or correlated) with Adial Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adial Pharmaceuticals has no effect on the direction of PsyBio Therapeutics i.e., PsyBio Therapeutics and Adial Pharmaceuticals go up and down completely randomly.

Pair Corralation between PsyBio Therapeutics and Adial Pharmaceuticals

Assuming the 90 days horizon PsyBio Therapeutics Corp is expected to generate 31.35 times more return on investment than Adial Pharmaceuticals. However, PsyBio Therapeutics is 31.35 times more volatile than Adial Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Adial Pharmaceuticals is currently generating about 0.02 per unit of risk. If you would invest  0.01  in PsyBio Therapeutics Corp on September 17, 2024 and sell it today you would earn a total of  0.00  from holding PsyBio Therapeutics Corp or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.46%
Values	Daily Returns

PsyBio Therapeutics Corp  vs.  Adial Pharmaceuticals

PsyBio Therapeutics Corp

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in PsyBio Therapeutics Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental drivers, PsyBio Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Adial Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Adial Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent forward indicators, Adial Pharmaceuticals is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with PsyBio Therapeutics and Adial Pharmaceuticals

The main advantage of trading using opposite PsyBio Therapeutics and Adial Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PsyBio Therapeutics position performs unexpectedly, Adial Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adial Pharmaceuticals will offset losses from the drop in Adial Pharmaceuticals' long position.

The idea behind PsyBio Therapeutics Corp and Adial Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.